TY  - JOUR
AU  - García-Robles, Ana
AU  - Gimeno Navarro, Ana
AU  - Serrano Martín, María Del Mar
AU  - Párraga Quiles, María José
AU  - Parra Llorca, Anna
AU  - Poveda-Andrés, José Luis
AU  - Vento Torres, Máximo
AU  - Aguar Carrascosa, Marta
PY  - 2020
DO  - 10.3389/fped.2020.00372
SN  - 2296-2360
UR  - https://hdl.handle.net/10668/25924
T2  - Frontiers in pediatrics
AB  - Background: Currently, the first line treatment of persistent ductus arteriosus (PDA) is either indomethacin or ibuprofen. However, the potentially life-threatening side effects associated to their use have prompted physicians to look for alternative...
LA  - en
KW  - ductus
KW  - efficacy
KW  - paracetamol
KW  - pharmacogenetics
KW  - pharmacokinetics
KW  - safety
TI  - Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol.
TY  - research article
VL  - 8
ER  -